ID   NEUL4_HUMAN             Reviewed;        1562 AA.
AC   Q96JN8; Q6GPI8; Q96IU9; Q9H0B0;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 2.
DT   07-APR-2021, entry version 143.
DE   RecName: Full=Neuralized-like protein 4;
GN   Name=NEURL4; Synonyms=KIAA1787;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11347906; DOI=10.1093/dnares/8.2.85;
RA   Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XX. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 8:85-95(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 47-1562 (ISOFORM 2).
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 735-1562 (ISOFORM 2), AND VARIANT
RP   HIS-1019.
RC   TISSUE=Kidney, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-907, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   FUNCTION, INTERACTION WITH CCP110, AND SUBCELLULAR LOCATION.
RX   PubMed=22441691; DOI=10.1038/embor.2012.40;
RA   Li J., Kim S., Kobayashi T., Liang F.X., Korzeniewski N., Duensing S.,
RA   Dynlacht B.D.;
RT   "Neurl4, a novel daughter centriole protein, prevents formation of ectopic
RT   microtubule organizing centres.";
RL   EMBO Rep. 13:547-553(2012).
RN   [7]
RP   INTERACTION WITH UBE3A AND MAPK6.
RX   PubMed=22645313; DOI=10.1128/mcb.00201-12;
RA   Martinez-Noel G., Galligan J.T., Sowa M.E., Arndt V., Overton T.M.,
RA   Harper J.W., Howley P.M.;
RT   "Identification and proteomic analysis of distinct UBE3A/E6AP protein
RT   complexes.";
RL   Mol. Cell. Biol. 32:3095-3106(2012).
RN   [8]
RP   FUNCTION, INTERACTION WITH CEP97; CCP110 AND HERC2, SUBCELLULAR LOCATION,
RP   AND UBIQUITINATION.
RX   PubMed=22261722; DOI=10.1074/mcp.m111.014233;
RA   Al-Hakim A.K., Bashkurov M., Gingras A.C., Durocher D., Pelletier L.;
RT   "Interaction proteomics identify NEURL4 and the HECT E3 ligase HERC2 as
RT   novel modulators of centrosome architecture.";
RL   Mol. Cell. Proteomics 11:M111.014233.01-M111.014233.14(2012).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-502, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   STRUCTURE BY NMR OF 42-205.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the NEUZ domain in KIAA1787 protein.";
RL   Submitted (JUN-2007) to the PDB data bank.
CC   -!- FUNCTION: Promotes CCP110 ubiquitination and proteasome-dependent
CC       degradation. By counteracting accumulation of CP110, maintains normal
CC       centriolar homeostasis and preventing formation of ectopic microtubular
CC       organizing centers. {ECO:0000269|PubMed:22261722,
CC       ECO:0000269|PubMed:22441691}.
CC   -!- SUBUNIT: Interacts with CCP110; this interaction propmotes CCP110
CC       ubiquitination and degradation via the proteasome pathway. Via its
CC       interaction with CCP110, may indirectly interact with CEP97. Interacts
CC       with the E3 ubiquitin-protein ligase HERC2 and UBE3A. May interact with
CC       MAPK6 and hence mediate MAPK6 interaction with UBE3A. Interaction with
CC       UBE3A may be indirect and mediated by HERC2.
CC       {ECO:0000269|PubMed:22261722, ECO:0000269|PubMed:22441691,
CC       ECO:0000269|PubMed:22645313}.
CC   -!- INTERACTION:
CC       Q96JN8; O43303: CCP110; NbExp=9; IntAct=EBI-1053406, EBI-1566217;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome, centriole {ECO:0000269|PubMed:22261722,
CC       ECO:0000269|PubMed:22441691}. Note=Localizes to procentriole and
CC       daughter centriole in growing and quiescent cells (PubMed:22441691).
CC       May loose association with centrosomes during mitosis
CC       (PubMed:22261722). {ECO:0000269|PubMed:22261722,
CC       ECO:0000269|PubMed:22441691}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96JN8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96JN8-2; Sequence=VSP_027563;
CC   -!- TISSUE SPECIFICITY: Widely expressed at high levels (including brain).
CC       {ECO:0000269|PubMed:11347906}.
CC   -!- DOMAIN: The third NHR domain (NHR 3) is required for localization to
CC       both mother and daughter centrioles. NHR 1 restricts targeting to
CC       daughter centriole (PubMed:22441691). NHR 3 and 4 are required for
CC       CCP110/CEP97-binding, but not for HERC2-binding. NHR 5 and 6 are
CC       important for HERC2-binding and centrosomal localization
CC       (PubMed:22261722). {ECO:0000269|PubMed:22261722,
CC       ECO:0000269|PubMed:22441691}.
CC   -!- PTM: Ubiquitinated; undergoes HERC2-dependent 'Lys-48' ubiquitination.
CC       This ubiquitination leads to proteasomal degradation.
CC       {ECO:0000269|PubMed:22261722}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH07227.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAB47416.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB058690; BAB47416.1; ALT_INIT; mRNA.
DR   EMBL; AL136870; CAB66804.1; -; mRNA.
DR   EMBL; BC007227; AAH07227.1; ALT_FRAME; mRNA.
DR   EMBL; BC073134; AAH73134.1; -; mRNA.
DR   CCDS; CCDS42251.1; -. [Q96JN8-1]
DR   CCDS; CCDS42252.1; -. [Q96JN8-2]
DR   RefSeq; NP_001005408.1; NM_001005408.1. [Q96JN8-2]
DR   RefSeq; NP_115818.2; NM_032442.2. [Q96JN8-1]
DR   PDB; 2E63; NMR; -; A=43-205.
DR   PDBsum; 2E63; -.
DR   SMR; Q96JN8; -.
DR   BioGRID; 124095; 90.
DR   CORUM; Q96JN8; -.
DR   IntAct; Q96JN8; 167.
DR   MINT; Q96JN8; -.
DR   STRING; 9606.ENSP00000382390; -.
DR   iPTMnet; Q96JN8; -.
DR   PhosphoSitePlus; Q96JN8; -.
DR   BioMuta; NEURL4; -.
DR   DMDM; 156630938; -.
DR   EPD; Q96JN8; -.
DR   jPOST; Q96JN8; -.
DR   MassIVE; Q96JN8; -.
DR   MaxQB; Q96JN8; -.
DR   PaxDb; Q96JN8; -.
DR   PeptideAtlas; Q96JN8; -.
DR   PRIDE; Q96JN8; -.
DR   ProteomicsDB; 76995; -. [Q96JN8-1]
DR   ProteomicsDB; 76996; -. [Q96JN8-2]
DR   Antibodypedia; 48206; 14 antibodies.
DR   Ensembl; ENST00000315614; ENSP00000319826; ENSG00000215041. [Q96JN8-2]
DR   Ensembl; ENST00000399464; ENSP00000382390; ENSG00000215041. [Q96JN8-1]
DR   Ensembl; ENST00000671847; ENSP00000500916; ENSG00000288301. [Q96JN8-1]
DR   Ensembl; ENST00000673081; ENSP00000500667; ENSG00000288301. [Q96JN8-2]
DR   GeneID; 84461; -.
DR   KEGG; hsa:84461; -.
DR   UCSC; uc002gga.2; human. [Q96JN8-1]
DR   CTD; 84461; -.
DR   DisGeNET; 84461; -.
DR   GeneCards; NEURL4; -.
DR   HGNC; HGNC:34410; NEURL4.
DR   HPA; ENSG00000215041; Low tissue specificity.
DR   MIM; 615865; gene.
DR   neXtProt; NX_Q96JN8; -.
DR   OpenTargets; ENSG00000215041; -.
DR   PharmGKB; PA164723835; -.
DR   VEuPathDB; HostDB:ENSG00000215041.9; -.
DR   eggNOG; KOG4625; Eukaryota.
DR   GeneTree; ENSGT00940000159866; -.
DR   InParanoid; Q96JN8; -.
DR   OMA; SNTEIEW; -.
DR   OrthoDB; 74097at2759; -.
DR   PhylomeDB; Q96JN8; -.
DR   PathwayCommons; Q96JN8; -.
DR   BioGRID-ORCS; 84461; 8 hits in 996 CRISPR screens.
DR   EvolutionaryTrace; Q96JN8; -.
DR   GenomeRNAi; 84461; -.
DR   Pharos; Q96JN8; Tdark.
DR   PRO; PR:Q96JN8; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q96JN8; protein.
DR   Bgee; ENSG00000215041; Expressed in adult mammalian kidney and 182 other tissues.
DR   ExpressionAtlas; Q96JN8; baseline and differential.
DR   Genevisible; Q96JN8; HS.
DR   GO; GO:0005814; C:centriole; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   Gene3D; 2.60.120.920; -; 6.
DR   InterPro; IPR043136; B30.2/SPRY_sf.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR037962; Neuralized.
DR   InterPro; IPR006573; NHR_dom.
DR   PANTHER; PTHR12429; PTHR12429; 1.
DR   Pfam; PF07177; Neuralized; 6.
DR   SMART; SM00588; NEUZ; 6.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   PROSITE; PS51065; NHR; 6.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Cytoskeleton;
KW   Phosphoprotein; Reference proteome; Repeat; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN           1..1562
FT                   /note="Neuralized-like protein 4"
FT                   /id="PRO_0000299105"
FT   DOMAIN          41..207
FT                   /note="NHR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00400"
FT   DOMAIN          317..484
FT                   /note="NHR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00400"
FT   DOMAIN          520..686
FT                   /note="NHR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00400"
FT   DOMAIN          716..884
FT                   /note="NHR 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00400"
FT   DOMAIN          913..1086
FT                   /note="NHR 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00400"
FT   DOMAIN          1131..1294
FT                   /note="NHR 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00400"
FT   MOD_RES         502
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         907
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VAR_SEQ         863..864
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11230166,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_027563"
FT   VARIANT         1019
FT                   /note="Q -> H (in dbSNP:rs3809813)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_049527"
FT   CONFLICT        228
FT                   /note="T -> S (in Ref. 2; CAB66804)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        359
FT                   /note="D -> G (in Ref. 2; CAB66804)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        637
FT                   /note="T -> A (in Ref. 2; CAB66804)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1262
FT                   /note="G -> A (in Ref. 3; AAH07227)"
FT                   /evidence="ECO:0000305"
FT   STRAND          50..54
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   STRAND          56..58
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   STRAND          60..64
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   TURN            66..68
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   STRAND          86..94
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   STRAND          103..109
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   HELIX           120..122
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   STRAND          125..139
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   STRAND          141..145
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   HELIX           150..152
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   STRAND          159..163
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   STRAND          169..175
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   STRAND          177..182
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   STRAND          189..194
FT                   /evidence="ECO:0007744|PDB:2E63"
FT   STRAND          199..204
FT                   /evidence="ECO:0007744|PDB:2E63"
SQ   SEQUENCE   1562 AA;  166907 MW;  CB25753A5D127246 CRC64;
     MAAGSGGSGG SGGGPGPGPG GGGGPSGSGS GPGSNGGLGS GGELHPRTGR LVSLSACGRT
     ARRQQPGQEF NHGLVLSREP LRDGRVFTVR IDRKVNSWSG SIEIGVTALD PSVLDFPSSA
     TGLKGGSWVV SGCSVLRDGR SVLEEYGQDL DQLGEGDRVG VERTVAGELR LWVNGRDCGV
     AATGLPPRVW AVVDLYGKCT QITVLPPEPG FSPPTPIPTP PLEPLAPTED SALAEQGTSA
     DEAFMVSPAQ ARPETFPNSL ESHNDFANME LSEVVSNTIL SAYNGGLLNV NLSSPPAGEG
     LGSSGAATSP ILTSNDALLF HEKCGTLIKL SNNNKTAERR RPLDEFNNGV VMTNRPLRDN
     EMFEIRIDKL VDKWSGSIEI GVTTHNPNSL EYPATMTNLQ SGTIMMSGCG ILTNGKGTRR
     EYCEFSLDEL QEGDHIGLTR KSNSALHFFI NGIDQGVATP LTPPVVYGVV DLYGMAVKVT
     IVHNNNHSDR LRRNNAILRA LSPEGALRRA APAAQAEPER LLFHPNCGQK AAITHEGRTA
     LRPHATDDFN HGVVLSSRAL RDGEVFQVRI DKMVDKWAGS IEIGVTTHNP AYLQLPSTMT
     NLRSGTWMMT GNGVMHNGTT ILDEYGHNLD RLKAGDTVGV VRREDGTLHF FVNGMTQGPA
     AWNVPPGVYA VVDLYGQAAQ ATIVDDVEVA PVPEPLPEGN NQVSPSSPSS GAGGSDLRFH
     QLHGSNAVIT NGGRTALRHN CRSEFNDAIV ISNRALRDGE LFEIVIQKMV DRWSGSIEAG
     VTAIRPEDLE FPNTMTDIDY DTWMLSGTAI MQDGNTMRNN YGCDLDALGT GARIGMMRTA
     KGDLHYFING QDQGAACSGL PPGKEVYAVV DLYGQCVQVS ITNATGPMDN SLATSNTATE
     KSFPLHSPVA GVAHRFHSTC GKNVTLEEDG TRAVRAAGYA HGLVFSTKEL RAEEVFEVKV
     EELDEKWAGS LRLGLTTLAP GEMGPGAGGG GPGLPPSLPE LRTKTTWMVS SCEVRRDGQL
     QRMNYGRNLE RLGVGSRVGV RRGADDTMHI LVDGEDMGPA ATGIAKNVWA VLDLYGPVRG
     VSIVSSTRLE ESEGTQPPSP SSDTGSEGEE DDEGEEHGLG GQNEVGIIPT TLEFLENHGK
     NILLSNGNRT ATRVASYNQG IVVINQPLVP QLLVQVRIDF LNRQWTSSLV LGVITCAPER
     LNFPASACAL KRAAWLLRGR GVFHNGLKIC EKFGPNLDTC PEGTILGLRL DSSGGLHLHV
     NGVDQGVAVP DVPQPCHALV DLYGQCEQVT IVNPEPGAAS GKSAGTQGDM EKADMVDGIK
     ESVCWGPPPA ASPLKSCEYH ALCSRFQELL LLPEDYFMPP PKRSLCYCES CRKLRGDEAH
     RRRGEPPREY ALPFGWCRFN LRVNPRLEAG TLTKKWHMAY HGSNVAAVRR VLDRGELGAG
     TASILSCRPL KGEPGVGFEE PGENCAPPRE EQPPPVLLSP SLQYAGAETL ASKVQFRDPK
     SQRTHQAQVA FQVCVRPGSY TPGPPSAALG EPPDPHFSPA ELEWVTKEKG ATLLCALLVR
     VE
//
